Walleye Capital’s abrdn Healthcare Investors HQH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-29,749
Closed -$477K 4609
2024
Q4
$477K Buy
+29,749
New +$528K ﹤0.01% 3033
2023
Q4
Sell
-35,591
Closed -$553K 5185
2023
Q3
$553K Buy
35,591
+13,413
+60% +$224K ﹤0.01% 2736
2023
Q2
$378K Sell
22,178
-9,150
-29% -$159K ﹤0.01% 2642
2023
Q1
$553K Buy
31,328
+13,180
+73% +$240K 0.01% 1626
2022
Q4
$327K Buy
18,148
+7,836
+76% +$145K 0.01% 1728
2022
Q3
$178K Buy
+10,312
New +$197K ﹤0.01% 2187
2020
Q4
Sell
-25,448
Closed -$525K 1006
2020
Q3
$525K Buy
25,448
+11,989
+89% +$253K 0.06% 386
2020
Q2
$287K Sell
13,459
-14,377
-52% -$293K 0.06% 347
2020
Q1
$496K Buy
27,836
+6,700
+32% +$132K 0.11% 227
2019
Q4
$441K Buy
21,136
+8,100
+62% +$160K 0.03% 733
2019
Q3
$239K Buy
+13,036
New +$251K 0.01% 1107

Other funds holding HQH

Walleye Capital's HQH Position: Q1 2025 in Review

Walleye Capital sold out of abrdn Healthcare Investors (HQH) in Q1 2025, closing a stake of 29,749 shares — an estimated $477K sold.

Walleye Capital first reported a position in HQH in Q3 2019 and held it in 11 quarters. The position peaked at $553K in Q3 2023. 105 funds tracked by Wall St. Rank hold HQH as of Q1 2025.

  • Walleye Capital reported no remaining abrdn Healthcare Investors position as of Q1 2025 after selling out during the quarter.
  • Walleye Capital sold 29,749 abrdn Healthcare Investors shares in Q1 2025, an estimated $477K.
  • Walleye Capital first reported a position in abrdn Healthcare Investors in Q3 2019 and held it in 11 quarters.
  • Walleye Capital's abrdn Healthcare Investors position peaked at $553K in Q3 2023.
  • 105 funds tracked by Wall St. Rank held abrdn Healthcare Investors as of Q1 2025.

Based on Walleye Capital's 13F filing for Q1 2025, filed 14 May 2025.